Diverse influences on tau aggregation and implications for disease progression

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Tau protein is intrinsically disordered and prone to forming fibrillar aggregates in neurodegenerative conditions.
• Tau misfolding is an equilibrium influenced by biochemical and cellular factors, leading to fibril formation and propagation.
• Tau pathology is implicated in diseases like Alzheimer's and contributes to disease progression via "prion-like" spread.

Purpose of the Study:

• To review the biochemical and cellular pathways that modulate tau aggregation.
• To discuss the implications of these pathways for neurodegenerative disease pathobiology.
• To explore potential tau-directed therapeutic approaches.

Main Methods:

• Literature review of biochemical and cellular mechanisms affecting tau aggregation.
• Analysis of factors influencing tau fibril formation, structure, and propagation.
• Discussion of cellular processes and microenvironmental interactions impacting tau pathology.

Main Results:

• Biochemical factors (ionic conditions, PTMs, cofactors) modulate tau fibril formation and structure.
• Cellular processes (stability, clearance, transport) significantly impact tau aggregation.
• Neuronal-glial interactions and the microenvironment influence intraneuronal tau conditions and toxicity.

Conclusions:

• Understanding tau aggregation pathways is crucial for deciphering neurodegenerative disease mechanisms.
• Tau fibril propagation suggests a "prion-like" spread contributing to disease progression.
• Targeting biochemical and cellular pathways offers potential for novel tau-directed therapies.